达托波塔马布德鲁克斯特坎:第一次批准
1Springer Nature, Private Bag 65901, Mairangi Bay, Auckland, 0754, New Zealand. dru@adis.com.
Drugs
|May 5, 2025
概括
达托帕马布德鲁克斯泰坎 (Datopotamab deruxtecan) 是一种针对TROP2的抗体-药物联合体,在日本,美国和欧盟获得了针对特定类型的乳腺癌的批准. 这标志着治疗激素受体阳性,HER2阴性晚期乳腺癌的重要里程碑.
科学领域:
- 在瘤学瘤学.
- 药理学 药理学是指药理学的学科.
- 药物开发 药物开发
背景情况:
- 达托帕马布德鲁克斯泰坎 (DATROWAY®) 是一种抗体-药物联体,向热囊细胞表面抗原2 (TROP2).
- 它是由Daiichi Sankyo和AstraZeneca开发的,用于治疗固体瘤.
- 这种结合体代表了瘤学中一种新的治疗方法.
研究的目的:
- 为了总结datopotamab deruxtecan.can的发展里程碑.
- 为了突出其最近批准的特定乳腺癌指示.
- 提供其监管旅程的概述.
主要方法:
- 审查监管文件和临床开发数据.
- 对批准日期和地理区域的分析.
- 总结患者群体和先前治疗标准.
主要成果:
- 达托帕马布德鲁克斯坦在日本获得批准 (2024年12月27日) 用于HR+,HER2-不可切除或复发性乳腺癌的化疗后治疗.
- 美国批准 (2025年1月17日) 已授予不可切除或转移的HR+,HER2-乳腺癌,此前已接受内分泌治疗和化疗.
- 在内分泌疗法和至少一种化疗线后,获得了欧盟批准用于不可切除或转移的HR+,HER2乳腺癌.
结论:
- 达托帕马布 (Datopotamab deruxtecan) 已经通过最初的批准取得了重要的监管里程碑.
- 这些批准针对HR+,HER2-高级乳腺癌的特定,未得到满足的需求.
- 加拿大和中国正在进行进一步的监管审查.
相关概念视频
Tumor Immunotherapy
2.5K
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
2.5K
Cancer Vaccines
1.3K
Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
1.3K
FDA Approved Drugs: Changes to Approved Drugs
343
Post-approval, manufacturers may modify an approved new or generic drug product. Such modifications can encompass alterations in the Active Pharmaceutical Ingredient (API), manufacturing process, formulation, batch size, manufacturing site, and container closure system (FDA Guidance for Industry, April 2004). Often, a drug product may undergo multiple changes.These modifications require careful evaluation to determine their potential impact on the drug product's identity, strength, quality,...
343
Therapeutic Drug Monitoring: Overview and Classification
638
Therapeutic Drug Monitoring (TDM) is a clinical practice that measures specific drug levels in a patient's blood at designated intervals to ensure the drug concentration stays within a therapeutic range. This monitoring is crucial for optimizing individual dosage regimens, enhancing therapeutic efficacy, and minimizing drug-related toxicity. TDM is vital for drugs with narrow therapeutic windows, significant variability in pharmacokinetics, and a clear correlation between plasma levels and...
638


